Synergy for Women's Health
Fat loss + GH optimization. AOD-9604 targets lipolysis while CJC-1295 elevates GH for body composition.
In the context of women's health, AOD-9604 and CJC-1295 (No DAC) work synergistically through complementary mechanisms. AOD-9604 (modified c-terminal fragment of human growth hormone that stimulates lipolysis via beta-3 adrenergic receptors without gh side effects.) and CJC-1295 (No DAC) (short-acting ghrh analog (mod grf 1-29) that stimulates pulsatile gh release mimicking natural physiological rhythms.) address different aspects of the same health goal, making their combination particularly effective for female physiology.
Combined Protocol
| Compound | Dose | Frequency | Category |
|---|---|---|---|
| AOD-9604 | 300mcg - 500mcg | Daily (fasted) | Weight Management |
| CJC-1295 (No DAC) | 100mcg - 200mcg | 2-3x daily (with Ipamorelin) | Anti-Aging & GH |
Get This Protocol
Alukard provides physician-supervised AOD-9604 + CJC-1295 (No DAC) protocols for women with GMP-certified compounds.
Get ProtocolStart Your Women's Health Protocol for AOD-9604 + CJC-1295 (No DAC) Stack
Alukard provides physician-supervised women's health protocols with GMP-certified compounds, comprehensive hormone panels, and personalized programs.
HIPAA Compliant · GMP Certified · Physician Supervised